| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 25,000 | $18.44 | $460,977.50 | -15.3% | |
| Jan 8, 2020 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 2,632 | $111.11 | $292,444.94 | -30.5% | |
| Jan 8, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 172,650 | $133.32 | $23,018,105.43 | - | |
| Jan 7, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 32,645 | $132.90 | $4,338,579.26 | - | |
| Jan 3, 2020 | AMRN Amarin Corp Plc\uk | Zakrzewski Joseph S55 | Director | Sell | 300,000 | $20.94 | $6,282,870.00 | -78.0% | |
| Jan 2, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 1,000 | $19.14 | $19,141.60 | -1.3% | |
| Dec 31, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sell | 2,459 | $9.92 | $24,396.23 | -9.8% | |
| Dec 23, 2019 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 1,000 | $45.92 | $45,920.00 | -8.7% | |
| Dec 20, 2019 | PRGO Perrigo Co Plc | Kingma Todd W | Executive VP, General Counsel | Sell | 2,300 | $54.91 | $126,293.00 | -3.6% | |
| Dec 20, 2019 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 19,260 | $20.85 | $401,601.82 | -3.3% | |
| Dec 20, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 19,705 | $132.90 | $2,618,812.23 | - | |
| Dec 20, 2019 | AYTU Aytu Biopharma, Inc | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 78,788 | $0.86 | $67,749.80 | +0.2% | |
| Dec 19, 2019 | AYTU Aytu Biopharma, Inc | Disbrow Joshua R.57 | Chief Executive Officer | Buy | 55,000 | $0.89 | $48,824.00 | +5.6% | |
| Dec 19, 2019 | AZN Astrazeneca Plc | Astrazeneca Plc | 10% Owner | Buy | 12,946,900 | $0.00 | - | New | |
| Dec 18, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 8,205 | $19.13 | $156,957.55 | -5.6% | |
| Dec 18, 2019 | PLSH Panacea Life Sciences Holdings, Inc. | Johnson Andrew L. | Chief Strategy Officer | Buy | 62,500 | $0.40 | $25,000.00 | +7.9% | |
| Dec 18, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 220,000 | $129.29 | $28,443,847.58 | - | |
| Dec 18, 2019 | BUDZ Weed, Inc. | Kwestel Elliot | Director Of Weed Israel Ltd. | Sell | 59,000 | $0.34 | $20,282.80 | -26.0% | |
| Dec 17, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 215,000 | $125.69 | $27,023,552.38 | - | |
| Dec 16, 2019 | AMRN Amarin Corp Plc\uk | Zakrzewski Joseph S55 | Director | Sell | 100,000 | $25.83 | $2,583,380.00 | -54.2% | |
| Dec 16, 2019 | PCRX Pacira Biosciences, Inc. | McLoughlin Dennis64 | Chief Commercial Officer | Sell | 3,671 | $45.79 | $168,107.94 | -18.6% | |
| Dec 16, 2019 | AMRN Amarin Corp Plc\uk | Berg Aaron | Chief Commercial Officer | Sell | 43,253 | $25.46 | $1,101,364.11 | -24.4% | |
| Dec 16, 2019 | ZTS Zoetis Inc. | Lewis Clinton A. Jr.46 | Executive Vice President | Sell | 6,123 | $124.93 | $764,946.39 | -18.0% | |
| Dec 16, 2019 | AMRN Amarin Corp Plc\uk | Kalb Michael Wayne | SVP And CFO | Sell | 25,000 | $23.36 | $584,011.53 | -20.7% | |
| Dec 16, 2019 | LNTH Lantheus Holdings, Inc. | Marshall Robert J. Jr.53 | CFO And Treasurer | Sell | 6,351 | $20.82 | $132,227.82 | -10.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.